David Frawley

No más puestos en curso

Health Technology

Consumer Services

Perfil

David Frawley worked as EVP & Chief Commercial Officer at Sumitomo Pharma America, Inc. and as SVP-GMSA, Customer Excellence & Operations at Karyopharm Therapeutics, Inc. He holds an MBA from the University of Bradford and an undergraduate degree from The University of Southampton.

Antiguos cargos conocidos de David Frawley.

Empresas	Cargo	Fin
Sumitomo Pharma America, Inc. Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA.	Corporate Officer/Principal	01/01/2019
KARYOPHARM THERAPEUTICS INC.	Corporate Officer/Principal	-

Ver el detalle de la experiencia de David Frawley.

Formación de David Frawley.

University of Bradford	Masters Business Admin
The University of Southampton	Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas